These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2054443)

  • 1. Detection of psychoactive drugs in vivo in humans using 19F NMR spectroscopy.
    Komoroski RA; Newton JE; Karson C; Cardwell D; Sprigg J
    Biol Psychiatry; 1991 Apr; 29(7):711-4. PubMed ID: 2054443
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine and trifluoperazine in human brain: a 19F-nuclear magnetic resonance spectroscopy study.
    Karson CN; Newton JE; Mohanakrishnan P; Sprigg J; Komoroski RA
    Psychiatry Res; 1992 Aug; 45(2):95-104. PubMed ID: 1362616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 19F nuclear magnetic resonance spectroscopy of neuroleptics: the first in vivo pharmacokinetics of trifluoperazine in the rat brain and the first in vivo spectrum of fluphenazine in the human brain.
    Bartels M; Günther U; Albert K; Mann K; Schuff N; Stuckstedte H
    Biol Psychiatry; 1991 Oct; 30(7):656-62. PubMed ID: 1958765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo 19F nuclear magnetic resonance spectroscopy of trifluorinated neuroleptics in the rat.
    Albert K; Rembold H; Kruppa G; Bayer E; Bartels M; Schmalzing G
    NMR Biomed; 1990 Jun; 3(3):120-3. PubMed ID: 2386658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration.
    Renshaw PF; Guimaraes AR; Fava M; Rosenbaum JF; Pearlman JD; Flood JG; Puopolo PR; Clancy K; Gonzalez RG
    Am J Psychiatry; 1992 Nov; 149(11):1592-4. PubMed ID: 1415832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluoxetine and fluvoxamine in depressed patients: personal results.
    Bouquet S; Vandel S; Bertschy G; Bonin B; Vandel B; Sechter D; Bizouard P
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():82A-83A. PubMed ID: 1499006
    [No Abstract]   [Full Text] [Related]  

  • 7. Duration of lithium treatment and brain lithium concentration in patients with unipolar and schizoaffective disorder--a study with magnetic resonance spectroscopy.
    Riedl U; Barocka A; Kolem H; Demling J; Kaschka WP; Schelp R; Stemmler M; Ebert D
    Biol Psychiatry; 1997 Apr; 41(8):844-50. PubMed ID: 9099410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemical discrimination of subtypes of depressive disorders: an outline of our studies on norepinephrine metabolism and psychoactive drugs in the endogenous depressions since 1967.
    Schildkraut JJ
    Pharmacopsychiatria; 1982 Jul; 15(4):121-7. PubMed ID: 7146090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo 19F spin relaxation and localized spectroscopy of fluoxetine in human brain.
    Komoroski RA; Newton JE; Cardwell D; Sprigg J; Pearce J; Karson CN
    Magn Reson Med; 1994 Feb; 31(2):204-11. PubMed ID: 8133756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of psychoactive drugs using 19F MR spectroscopy.
    Bartels M; Albert K
    J Neural Transm Gen Sect; 1995; 99(1-3):1-6. PubMed ID: 8579798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine resolves psychotic depression in an adolescent boy.
    Padla D
    J Child Adolesc Psychopharmacol; 2001; 11(2):207-8. PubMed ID: 11436964
    [No Abstract]   [Full Text] [Related]  

  • 12. Human brain fluoxetine concentrations.
    Karson CN; Newton JE; Livingston R; Jolly JB; Cooper TB; Sprigg J; Komoroski RA
    J Neuropsychiatry Clin Neurosci; 1993; 5(3):322-9. PubMed ID: 8369643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trifluoperazine plasma levels and clinical response.
    Janicak PG; Javaid JI; Sharma RP; Comaty JE; Peterson J; Davis JM
    J Clin Psychopharmacol; 1989 Oct; 9(5):340-6. PubMed ID: 2794098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoxetine: an alternative to the tricyclics in the treatment of major depression?
    Tacke U
    Am J Med Sci; 1989 Aug; 298(2):126-9. PubMed ID: 2669476
    [No Abstract]   [Full Text] [Related]  

  • 15. Fluoxetine for depression.
    Med Lett Drugs Ther; 1988 Apr; 30(764):45-7. PubMed ID: 3258399
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report.
    Bashford G; Bradd P
    J Geriatr Psychiatry Neurol; 1996 Jul; 9(3):133-5. PubMed ID: 8873877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of trifluoperazine with porcine calmodulin 19F NMR and induced CD spectral studies.
    Shimizu T; Hatano M
    FEBS Lett; 1983 Aug; 160(1-2):182-6. PubMed ID: 6411490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of fluoxetine and valproic acid.
    Lucena MI; Blanco E; Corrales MA; Berthier ML
    Am J Psychiatry; 1998 Apr; 155(4):575. PubMed ID: 9546010
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear magnetic resonance (NMR): I. Imaging biochemical change.
    Eastwood LM; Hutchison JM; Besson JA
    Br J Psychiatry; 1985 Jan; 146():26-31. PubMed ID: 2983816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 19F magnetic resonance spectroscopy investigation in vivo of acute and steady-state brain fluvoxamine levels in obsessive-compulsive disorder.
    Strauss WL; Layton ME; Hayes CE; Dager SR
    Am J Psychiatry; 1997 Apr; 154(4):516-22. PubMed ID: 9090339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.